Skip to main content

Top Federal Health Official Says Marijuanas Legal Status Is Inhibiting Research

A top federal health official said on Wednesday that marijuana’s status as a Schedule I controlled substance inhibits research and that there’s a need for an alternative regulatory pathway so that researchers can more easily study cannabis.

During a hearing before the House Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittee, Rep. Barbara Lee (D-CA) shared an anecdote about cannabis lotion helping her mother treat pain in her knees and asked what could be done to facilitate research into marijuana’s therapeutic potential.

Lee said that following knee surgery, her mom “was out getting her walker repaired and a woman gave her some lotion and she tried it and she never was in pain anymore.”

“This was cannabis lotion, so I have witnessed at least my mother and other senior citizens the health benefits of cannabis,” she said. “I know good and well, based on personal experience, that it works for some people.”

The congresswoman then asked witnesses at the hearing for an update on the status of federally approved research into marijuana’s medical benefits.

“The public is using this and so we’re essentially now playing catch up with what’s already happening and we need to understand the potential beneficial effects of these compounds derived from cannabis, particularly for pain,” Helene Langevin, director of the National Center for Complementary and Integrative Health (NCCIH), said in response. “There’s a lot of potential there.”

She also noted that NCCIH her department is providing $3 million in grants to fund studies into the benefits of cannabis compounds beside THC, with a focus on developing therapeutic alternatives to prescription opioids.

“We really want to understand how it works but also we’re very interested in looking at potential interactions of cannabis with drugs,” Langevin said.

Lee followed up to ask the head of the National Institutes of Health (NIH) if it’s possible to catch up with the numerous states that have legalized medical cannabis in terms of research and, if not, “how can we help you catch up with where the states are?”

NIH Director Francis Collins put it plainly: “We do have a problem in that because marijuana is Schedule I, it is difficult to set up research programs.”

“We’ve certainly been talking about the need for some kind of alternative pathway so that we could do research on potential valuable uses of marijuana without going through such an incredibly bureaucratic rigmarole that it scares away most investigators from even doing the work,” he said. “And we could use some help from Congress in coming up with a better strategy about that part.”

That admission is similar to what the head of the National Institutes on Drug Abuse told the same committee in April.

“Indeed, the moment that a drug gets a Schedule I, which is done in order to protect the public so that they don’t get exposed to it, it makes research much harder,” NIDA Director Nora Volkow said at the time. “This is because [researchers] actually have to through a registration process that is actually lengthy and cumbersome.”

Later in Thursday’s hearing, anti-legalization Rep. Andy Harris (R-MD) flagged legislation he’s sponsoring to simplify the registration process for researchers to obtain cannabis and also allow them to access marijuana from private manufacturers.

“It’s been bouncing around for a couple of years and hopefully it has some legs that will make research into the potential medical benefits of marijuana much easier before it further expands with what I think a lot of false hopes,” he said, adding that studies have shown marijuana to interact with anesthesia.

“Clearly this is not a drug that acts only on its own and clearly interacts with other systems in the body, including analgesic systems, in ways that we don’t fully understand,” he said.

Senate Committee Declines To Expand State Marijuana Protections In Spending Bill

Photo by Aphiwat chuangchoem.

The post Top Federal Health Official Says Marijuana’s Legal Status Is Inhibiting Research appeared first on Marijuana Moment.

Original Article Source: https://www.marijuanamoment.net/top-federal-health-official-says-marijuanas-legal-status-is-inhibiting-research/

Comments

Post a Comment

Popular posts from this blog

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs
Post a Comment
Read more

Charlotte Figi The Girl Who Inspired A CBD Movement Has Died At Age 13

Charlotte had recently been hospitalized due to pneumonia, breathing problems and seizures. She was treated as a likely case of Covid-19, her mother, Paige Figi, said Wednesday, although she tested negative for the virus. “Charlotte is no longer suffering. She is seizure-free forever,” a family friend wrote on Paige Figi’s Facebook page, announcing Charlotte’s death. “Thank you so much for all of your love.” Charlotte became a symbol of the possibilities of CBD after CNN Chief Medical Correspondent Dr. Sanjay Gupta told her story in the documentary “Weed.” In the film, Charlotte was shown to be a playful child who was overcome by horrific seizures, which were quelled with Charlotte’s Web, a marijuana strain named in her honor. Charlotte had Dravet syndrome, a rare form of epilepsy which was not controlled by medication. The Stanley brothers, marijuana growers in Colorado, were crossbreeding a strain of marijuana high in CBD and low in THC, its psychoactive ingredient. After Charlo
Post a Comment
Read more

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multistate
Post a Comment
Read more